Literature DB >> 8828637

Nutrition and reproductive outcome in maternal phenylketonuria.

K Michals1, P B Acosta, V Austin, L Castiglioni, F Rohr, E Wenz, C Azen.   

Abstract

Maternal weight gain and intake of selected nutrients were correlated with plasma phenylalanine (Phe) concentrations and reproductive outcomes (in 150 and 142 subjects respectively) in the Maternal PKU Collaborative Study. Daily protein intake was negatively correlated with plasma Phe concentration. Birth length, weight and head circumference of offspring were negatively influenced by the length of time required for the maternal plasma Phe to decline below 600 mumol/l (10 mg/dl) and positively influenced by weight gain of mother as a percentage of recommended weight gain. Birth weight and length were positively correlated with maternal protein and energy intakes. During the first trimester, intakes of fat, calcium, phosphorus, vitamin A and folate were significantly greater in women who had a good reproductive outcome than by women who had a poor outcome. In addition to plasma Phe control in maternal phenylketonuria (PKU), maternal weight gain and dietary intake of protein, energy and fat were correlated with outcome. Therefore, nutrient intake and maternal weight gain should be considered along with plasma Phe concentration when managing the therapy of a pregnant woman with PKU.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8828637     DOI: 10.1007/pl00014239

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  9 in total

1.  Maternal phenylketonuria pregnancy outcome: a preliminary report of facial dysmorphology and major malformations.

Authors:  B Rouse; L Lockhart; R Matalon; C Azen; R Koch; W Hanley; H Levy; F dela Cruz; E Friedman
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Maternal PKU collaborative study: the effect of nutrient intake on pregnancy outcome.

Authors:  R Matalon; K Michals; C Azen; E G Friedman; R Koch; E Wenz; H Levy; F Rohr; B Rouse; L Castiglioni
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

3.  Nutrition in pregnancy of women with hyperphenylalaninemia.

Authors:  P B Acosta; M Blaskovics; H Cloud; E Lis; H Stroud; E Wenz
Journal:  J Am Diet Assoc       Date:  1982-05

4.  Fetal damage due to maternal phenylketonuria: effects of dietary treatment and maternal phenylalanine concentrations around the time of conception (an interim report from the UK Phenylketonuria Register).

Authors:  I Smith; J Glossop; M Beasley
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

5.  Influence of pregnancy weight gain on the size of infants born to underweight women.

Authors:  J E Brown; H N Jacobson; L H Askue; M G Peick
Journal:  Obstet Gynecol       Date:  1981-01       Impact factor: 7.661

6.  Is phenylalanine requirement in infants and children related to protein intake?

Authors:  E Kindt; K Motzfeldt; S Halvorsen; S O Lie
Journal:  Br J Nutr       Date:  1984-05       Impact factor: 3.718

7.  Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome.

Authors:  G S Tint; M Irons; E R Elias; A K Batta; R Frieden; T S Chen; G Salen
Journal:  N Engl J Med       Date:  1994-01-13       Impact factor: 91.245

8.  Protein intake affects phenylalanine requirements and growth of infants with phenylketonuria.

Authors:  P B Acosta; S Yannicelli
Journal:  Acta Paediatr Suppl       Date:  1994-12

9.  Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies.

Authors:  R R Lenke; H L Levy
Journal:  N Engl J Med       Date:  1980-11-20       Impact factor: 91.245

  9 in total
  5 in total

1.  Maternal Phenylketonuria Collaborative Study (MPKUCS)--the 'outliers'.

Authors:  W B Hanley; C Azen; R Koch; K Michals-Matalon; R Matalon; B Rouse; F Trefz; S Waisbren; F de la Cruz
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

2.  Maternal phenylketonuria: the French survey.

Authors:  François Feillet; Véronique Abadie; Jacques Berthelot; Nicole Maurin; Hélène Ogier; Michel Vidailhet; Jean-Pierre Farriaux; Loic de Parscau
Journal:  Eur J Pediatr       Date:  2004-07-06       Impact factor: 3.183

3.  Outcome implications of the International Maternal Phenylketonuria Collaborative Study (MPKUCS): 1994.

Authors:  R Koch; H Levy; W Hanley; R Matalon; B Rouse; F Trefz; F de la Cruz
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

4.  The International Collaborative Study on maternal phenylketonuria: organization, study design and description of the sample.

Authors:  E G Friedman; R Koch; C Azen; H Levy; W Hanley; R Matalon; B Rouse; F Trefz; F de la Cruz
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

Review 5.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.